Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T ZELLER

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Trials|October 30, 2016
The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trialU Teichgräber, R Aschenbach, D Scheinert, et al.
Trials|April 28, 2017
Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trialU Teichgräber, R Aschenbach, D Scheinert, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 27, 2010
Use of B-type natriuretic peptide to predict blood pressure improvement after percutaneous revascularisation for renal artery stenosisD Staub, T Zeller, D Trenk, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2008
Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene studyD A Tregouet, R Schnabel, M C Alessi, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 16, 2019
Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2T Reiff, H H Eckstein, U Mansmann, et al.
Respiratory Research|January 24, 2024
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONETS Fähndrich, C Herr, S Teuteberg, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Trials|October 30, 2016
The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trialU Teichgräber, R Aschenbach, D Scheinert, et al.
Trials|April 28, 2017
Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trialU Teichgräber, R Aschenbach, D Scheinert, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 27, 2010
Use of B-type natriuretic peptide to predict blood pressure improvement after percutaneous revascularisation for renal artery stenosisD Staub, T Zeller, D Trenk, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2008
Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene studyD A Tregouet, R Schnabel, M C Alessi, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 16, 2019
Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2T Reiff, H H Eckstein, U Mansmann, et al.
Respiratory Research|January 24, 2024
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONETS Fähndrich, C Herr, S Teuteberg, et al.
Pageof 7